Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: WALD

Waldencast plc

Technology | Software - Application

No licensed closing price on file for WALD. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$-2.01

Waldencast plc (NASDAQ: WALD) is an application software company. Figures from SEC EDGAR; updated 2026-10-20 05:21 UTC.

What Waldencast plc does

Waldencast operates two reporting units: Obagi Medical and Milk Makeup. The company was formed through business combinations involving the acquisition of Obagi and Milk Makeup. Waldencast conducts operations internationally and maintains various credit agreements to finance its business. The company is incorporated under the laws of the Cayman Islands and operates through multiple subsidiaries, including entities in Jersey and Delaware. Waldencast's products are subject to regulation by agencies including the FDA, FTC, and CPSC.

Summarized from Waldencast plc’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

WALD no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.

Key facts

Valuation
EPS (FY2025)$-2.01
Return on equity-49.74%
Debt/equity0.30

Revenue, margins & earnings

FY2021: net loss $20M on revenue $142M$142MFY2021FY2023: net loss $90M on revenue $218M$218MFY2023FY2024: net loss $42M on revenue $274M$274MFY2024FY2025: net loss $230M on revenue $272M$272MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-01
  • 2026-09-01DirectorPurchase335,000$505.6K
  • 2026-08-07Chief Executive OfficerRestricted Stock UnitsReturned to company-264,294$528.6K
  • 2026-08-07Chief Growth OfficerRestricted Stock UnitsReturned to company-193,816$387.6K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Waldencast plc do?

Waldencast operates two reporting units: Obagi Medical and Milk Makeup.

When did WALD last file with the SEC?

Waldencast plc's most recent SEC filing on record is a 6-K filed 2026-07-13. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:21 UTC. This page is also available as JSON at /api/data?ticker=WALD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for WALD and 5,000+ tickers.

Create a free account — keep WALD
For your agent
GET /api/data?ticker=WALD

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt